Nosocomial bloodstream infections in a Turkish university hospital: Study of Gram-negative bacilli and their sensitivity patterns

International Journal of Antimicrobial Agents

Volumn 17, Issue 6, 2001, Pages 477-481

  Köseolu, Özgen ^a   Kocagöz, Sesin ^a   Gür, Deniz ^a   Akova, Murat ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Antibacterial activity; Enterobacteriaceae

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; MEROPENEM; OFLOXACIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; TAZOBACTAM;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; ENTEROBACTER; ENTEROBACTERIACEAE; HOSPITAL INFECTION; HUMAN; KLEBSIELLA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSEUDOMONAS;

4-QUINOLONES; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTEREMIA; CARBAPENEMS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; TURKEY;

EID: 0034980845     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(01)00325-9     Document Type: Article

References (23)

1. The efficacy of infection surveillance and control programs in controlling programs in preventing nosocomial infections in US hospitals
2. Major trends in the microbial etiology of nosocomial infection
3. An overview of nosocomial infections, including the role of the microbiology laboratory
4. Nosocomial infection in an oncology intensive care unit
5. The prevalance of nosocomial infection in intensive care units in Europe. Results of the European Prevalance of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.
6. Problems and changing patterns of resistance with Gram-negative bacteria
7. A surveillance study of antimicrobial resistance of Gram-negative bacteria isolated from intensive care units in eight hospitals in Turkey
8. Risk factors for acquisition of multiply drug-resistant Gram-negative bacteria
9. Antibiotic resistance and production of extended-spectrum β-lactamases amongst Klebsiella spp. from intensive care units in Europe
10. The Sentry participants group. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the Sentry Antimicrobial Surveillance Program (United States and Canada, 1997)
11. Inducible AmpC β-lactamase producing Gram-negative bacilli from bloodstream infections: frequency, antimicrobial susceptibility and molecular epidemiology in a National Surveillance Program (SCOPE)
12. Antibiotic resistance patterns among blood culture isolates in a Danish country 1981-1995
13. Survey of bloodstream infections due to Gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997
14. Antimicrobial activity of 12 broad spectrum agents tested against 270 nosocomial bloodstream infection isolates caused by non-enteric Gram-negative bacilli: occurrence of resistance, molecular epidemiology and screening for metallo-enzymes
15. Transferable production of PER-1 beta-lactamase in Pseudomonas aeruginosa
16. Widespread detection of PER-1 type extended-spectrum beta lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study
17. Evaluation of new drugs
18. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin
19. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa; active efflux as a contributing factor to β-lactam resistance
20. Comparative evaluation of a new β-lactamase inhibitor, YTR 830, combined with different β-lactam antibiotics against bacteria harboring known β-lactamases
21. In vitro efficacy of various antibiotics against Gram-negative nosocomial bacteremia pathogens